Beta-1,3-Glucan (Yeast).
Yeast-derived immune modulator Yeast cell wall fibre that innate immune cells recognise through the dectin-1 receptor. It acts as a signal to normal immune defences rather than as a nutrient you absorb.
Reviewed March 2026
- Category
- Immune
What Beta-1,3-Glucan (Yeast) is, and what it does.
- Does it work
- Suits people who get run down through winter, parents of young kids, teachers and anyone in a heavy training block. It's a daily habit across a season, not a one-off.
- How much to take
- Start with 250mg a day, and 250 to 500mg daily is the maintenance band. A small steady amount is what a receptor signal needs, so consistency matters more than size.
- Time to feel it
- Nothing acute. Studies that follow immune markers and how often people get run down run four to twelve weeks, so judge it across a season.
- The first dose
- Day one is quiet. Immune tissue in the gut wall starts sampling the particles, and that reads out in immune markers over the following weeks.
- With regular use
- Weeks of daily use is where trial immune readouts move, and the practical read is how a season goes. Leftover glucan ferments in the colon and feeds butyrate production.
- How well tolerated
- Well tolerated at everyday amounts. If you react to yeast, check the source, and anyone taking immune-modulating medication should ask their clinician first.
- How it feels
- No sensation attached to it. The change shows up in immune markers and in how often you get run down across a season rather than on the day you take it.
- The overlooked benefit
- What isn't recognised by gut immune tissue gets fermented by colon bacteria into butyrate, the fuel those cells run on, so there's a gut arm alongside the immune one.
250 to 500mg a day is where Beta-1,3-Glucan (Yeast) works.
Source: Saeed et al. 2021 Nutrients review; Bashir & Choi 2017 Int J Mol Sci.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Beta-1,3-Glucan (Yeast) has solid evidence. Based on 2+ studies.
- Immune resilience through a heavy training blockRandomised trial
- Innate immune cell activity markersRandomised trial
- Dectin-1 receptor recognition of beta-1,3-glucanIn vitro study
- Salivary immunoglobulin A and mucosal defence markersRandomised trial
- Short chain fatty acid production during colonic fermentationIn vitro study
Questions people ask about Beta-1,3-Glucan (Yeast).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Colonic bacteria ferment beta-glucan and release short chain fatty acids, butyrate among them, which colonocytes use as their preferred fuel. Supplying butyrate directly and supplying its fermentable precursor reach the same end point by different routes.
Beta-glucan reaches the colon undigested by human enzymes and is fermented by resident bacteria, so it acts as substrate for the strains a probiotic delivers. Pairing a live strain with a substrate it can use is the standard synbiotic construction.
Inulin is fermented mainly in the proximal colon while beta-glucan ferments more slowly and further along, so together they spread short chain fatty acid production across a longer stretch of bowel. Blends use the two for that spread rather than for a shared receptor.
Beta-glucan is recognised by dectin-1 on monocytes and macrophages, and the vitamin D receptor is expressed in those same cells where calcitriol shapes their response. The two act on normal innate immune cell function through separate receptors.
Neutrophils concentrate ascorbate to millimolar levels and use it during their oxidative burst and in motility. Beta-glucan primes those cells through receptor binding while ascorbate supports the machinery they run on.
Zinc is a structural cofactor in hundreds of transcription factors and is needed for normal development and signalling of immune cells. It supports the cell population that beta-glucan's receptor binding acts on.
Lactoferrin sequesters free iron at mucosal surfaces and binds bacterial surface molecules, a mechanism entirely separate from dectin-1 receptor engagement. Formulators combine them so two independent innate mechanisms are covered.
Reishi cell walls carry their own beta-1,3/1,6 glucans plus triterpenes, so a blend delivers a wider range of glucan chain lengths and branching to the same receptor family. Long-standing blend practice rests on that structural variety.
Maitake D-fraction is a protein-bound beta-glucan with a distinct branching pattern from yeast-derived glucan. Both are recognised by dectin-1 and complement receptor 3 on innate immune cells.
Lentinan is a purified beta-1,3 glucan with 1,6 branches from shiitake, structurally close to yeast glucan and read by the same innate receptors. Blends pair them for chain-length variety.
PSP and PSK are polysaccharide-peptide complexes built on a beta-glucan backbone, so they engage the same glucan-recognising receptors while carrying a bound protein fraction yeast glucan lacks.
Selenium is built into glutathione peroxidases and thioredoxin reductases, which immune cells depend on to handle the oxidative burst they generate when activated. Beta-glucan works upstream of that, on pattern-recognition receptors that prime the cell in the first place. The two sit at different points of the same normal immune response.
Retinoic acid drives the differentiation of gut-associated immune cells and the maintenance of mucosal barrier tissue, which is where an orally taken particulate glucan is first sampled. Pairing the two supports the surface that does the sampling and the receptor signal being sampled. This is complementary physiology rather than a tested combination.
Alpha-tocopherol protects the polyunsaturated fatty acids in immune cell membranes from peroxidation, which matters most in cells that have been activated. Beta-glucan is an activator. The pairing is a mechanistic complement and has not been measured together.
Galactooligosaccharides are fermented preferentially by bifidobacteria in the colon. A yeast glucan preparation that reaches the colon intact is also fermentable material, and reviews of fungal glucans place part of their gut activity in that fermentation. Combining a selective and a non-selective substrate is a formulation choice, not a tested pairing.
Fructooligosaccharides are fermented to short-chain fatty acids and are the most common prebiotic pairing in immune-positioned blends. The rationale next to beta-glucan is that one feeds the microbial community and the other signals to innate immune receptors. No combination study defines the result.
Resistant starch escapes small-intestinal digestion and is fermented to butyrate in the colon, the fuel the colonic lining prefers. Yeast glucan preparations are studied for their effect on the same gut compartment. The two are complementary substrates rather than a studied pair.
A live bifidobacterium and an insoluble glucan particle reach the gut by different routes and are sensed by different receptors, so they are often combined in the same immune-positioned product. Reviews of fungal glucans describe gut-mediated innate signalling as part of the mechanism, which is where the overlap sits. Nothing establishes what the pair does together in a person.
Bacterial cell wall components are read by Toll-like receptors while fungal beta-glucan is read mainly by dectin-1 and complement receptor 3. Different receptors, same innate system, which is the argument for putting them together. It remains an argument from mechanism.
This probiotic is itself a yeast, so its cell wall carries the same class of beta-1,3/1,6-glucan that is extracted and sold as a supplement. Taking both means receiving glucan in a live-cell form and in a purified particle form. The overlap is structural and worth knowing when reading two labels together.
Bovine colostrum supplies immunoglobulins and lactoferrin that act in the gut lumen, while beta-glucan acts by engaging receptors on the cells lining and patrolling that lumen. The two occupy different halves of the immune response, which is the reason they are formulated together. Combination evidence in people is not established.
Elderberry contributes anthocyanins and is one of the most frequent companions to yeast glucan in seasonal immune products. The pairing is a formulation convention supported by each ingredient's own literature, not by a study of the two. Say that plainly rather than implying a combined effect.
Quercetin dampens several inflammatory signalling cascades in cell systems, which is a different direction of travel from a glucan that primes innate cells. That is not a contradiction, since priming and restraint can be complementary, but it is worth stating rather than smoothing over. No study measures the two together.
Pyridoxal 5-phosphate is the cofactor for the transaminases and decarboxylases that proliferating lymphocytes depend on. An immune cell that has been primed by a glucan still needs that cofactor supply to build and divide. This is settled biochemistry, not a combination finding.
Astaxanthin spans the lipid bilayer and quenches peroxidation there, which is relevant in activated phagocytes generating reactive oxygen species. Beta-glucan is what activates those cells. The pairing is mechanistic reasoning with no combination data behind it.
Psyllium forms a viscous gel and increases stool bulk, which changes transit time for anything travelling with it, including a particulate glucan. Whether that helps or hinders glucan sampling in the gut is not established. Flagged because tolerance, not efficacy, is the usual reason someone notices a two-fibre stack.
Nothing specific on file for Beta-1,3-Glucan (Yeast). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Beta-1,3-Glucan (Yeast) actually does.
Yeast beta-glucan is a linear beta-1,3-linked glucose backbone carrying beta-1,6-linked side branches. That branch pattern is what distinguishes it from the linear beta-1,3/1,4-glucan of oat and barley, and it is the structural feature innate immune receptors recognise.
Dectin-1 on macrophages, neutrophils and dendritic cells is the principal receptor for beta-1,3-glucan, with complement receptor 3 and CR3-bound iC3b providing a second route. Receptor engagement is a recognition event, which is why this ingredient is described as modulating a normal immune response rather than supplying a nutrient.
Humans produce no enzyme that cleaves beta-1,3 or beta-1,6 glucosidic bonds, so an oral dose is not digested for energy. It is sampled by gut immune tissue and fermented by colonic bacteria instead.
Particulate whole glucan particles are insoluble and behave as a particle that phagocytes can engulf, while alkali-solubilised or carboxymethylated preparations circulate and bind receptors in solution. The two behave differently in the body even though both are labelled beta-1,3-glucan.
Where Beta-1,3-Glucan (Yeast) comes from.
It comes from the wall of ordinary baker's yeast. The yeast cells are broken open, the inside is washed away, and what is left is the fibrous outer shell, cleaned with alkali, acid and solvent until it is mostly beta-glucan. The finished powder is an insoluble particle, and the certificate says what percentage of it is actually glucan.
Produced by a cultured organism rather than harvested. The strain is selected and the conditions are controlled, so batches sit closer together than a field crop.
Saccharomyces cerevisiae grown on a sugar substrate, or recovered as spent yeast from brewing. The cell wall is the target; the cytoplasm is a by-product stream that goes to yeast extract.
Cells are broken open, usually by autolysis or mechanical disruption, and the wall fraction is separated from the soluble interior by centrifugation and washing.
Hot alkali removes mannoprotein and much of the beta-1,6-linked material; a following acid step removes residual glycogen and protein. The harshness of these steps sets both the final assay and how much branching survives.
Lipid is removed with solvent or ethanol washes and the particle is repeatedly water-washed. Residual protein, mannan and ash are the specifications that separate one grade from another.
Batches are assayed for beta-glucan content by enzymatic or chemical method and characterised for particle size distribution. Both numbers matter, because dose and receptor interaction depend on them.
The washed particle is spray dried to a free-flowing off-white powder for capsules, tablets or sachets. It stays insoluble in water at this point.
Whether a batch came from purpose-grown yeast or from spent brewing yeast is often not stated, and the exact wash conditions that determine branching are treated as proprietary.
Getting Beta-1,3-Glucan (Yeast) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Baker's yeast beta-1,3/1,6-glucan raised markers of upper airway mucosal immune activity in healthy adults compared with placebo.Randomised trial. Kanno et al., 2026 (Nutrients). PMID 41901136 ↗
- Eight weeks of a yeast cell-derived beta-glucan product shifted redox and immune response markers in the adults studied.Randomised trial. König et al., 2026 (Nutrients). PMID 42197007 ↗
- Reviews fungal beta-1,3-glucans as cell wall constituents that engage innate immune receptors in the gut and describes the receptor and microbiota routes behind that.Narrative review. Samiksha F et al., 2026 (Nutrients). PMID 42280437 ↗
- A registered randomised protocol for a particulate yeast beta-glucan preparation in adults with seasonal upper-airway allergy symptoms; it sets out a design and reports no outcomes.Randomised trial. Briskey D et al., 2026 (Trials). PMID 41998746 ↗
- A registered randomised study of yeast beta-glucan 1,3/1,6 measuring respiratory symptom episodes, fatigue scores, immune markers and gut measures; several of its endpoints are markers rather than outcomes.Randomised trial. Mohamad Habibullah NN et al., 2025 (BMJ Open). PMID 39832981 ↗
- Reported improvement in cognitive test scores over a course of yeast beta-glucan given with multivitamins; a single-arm design with a multi-ingredient product, so the glucan cannot be separated from the vitamins.Open-label trial. Lacasa M et al., 2023 (Nutrients). PMID 37960157 ↗
- Chronic barley consumption was tested against upper respiratory tract symptom reporting in healthy adults; barley supplies cereal 1,3/1,4-glucan, a different structure from yeast 1,3/1,6-glucan.Randomised trial. Araki R et al., 2024 (Nutrients). PMID 39064742 ↗
- Reported fewer respiratory symptom episodes with pleuran, a mushroom-derived beta-glucan; the source organism differs from baker's yeast, so the result does not transfer directly.Randomised trial. Jesenak M et al., 2025 (Scientific Reports). PMID 40021713 ↗
- Dietary beta-glucan reduced heat-stress-related decline in performance and intestinal measures; an animal production study, so it grounds mechanism and not a human effect.Animal study. Abuajamieh M et al., 2026 (Veterinary World). PMID 42494684 ↗
- Immune stimulation depended on how long beta-1,3/1,6-glucan was administered, which is a duration finding in fish rather than a human dosing schedule.Animal study. Kazun B et al., 2026 (Journal of Veterinary Research). PMID 42440786 ↗
- Dietary yeast beta-glucan raised immune response measures and resilience to a pathogen challenge in fish; a non-human challenge model.Animal study. Cabano M et al., 2026 (Frontiers in Immunology). PMID 42088490 ↗
- A systematic review restricted to non-clinical studies of immune-active polysaccharides, beta-glucans among them; the authors are explicit that no human outcome data is included.Systematic review. Corso CR et al., 2021 (Nutrients). PMID 34200897 ↗
- A prebiotic carbohydrate altered virulence factor expression in a fungal species in culture, which speaks to how carbohydrates and fungal cell walls interact rather than to a supplement effect.In vitro study. Hickey E et al., 2026 (mBio). PMID 42132389 ↗
- Stress tolerance in a yeast tracked with changes in cell membrane and cell wall composition, the compartment that beta-1,3-glucan is extracted from.In vitro study. Liu X et al., 2026 (BMC Microbiology). PMID 42014992 ↗
These are the studies our verdict leans on, chosen from the 951 we read for Beta-1,3-Glucan (Yeast). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.